DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Socinski MA, Bondarenko I, Karaseva NA et al.
Weekly nab-paclitaxel in combination with carboplatin vs. solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial.
J Clin Oncol 2012;
30: 2055-2062
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.